Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Cross-over Trial to Evaluate the Efficacy and Safety Between Increasing the Dose of Iron and Original Iron Dosage in Patients With Maintenance Hemodialysis

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT04491916
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:37:37.842779+00:00
Published At
2020-07-30T00:00:00+00:00
Record Updated At
2020-07-30
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["End-stage Renal Disease", "Anemia", "Cardiovascular Risk Factor", "Inflammation"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2020-07-30"
protocolSection.identificationModule.nctId
"NCT04491916"
protocolSection.identificationModule.officialTitle
"A Cross-over Trial to Evaluate the Efficacy and Safety Between Increasing the Dose of Iron and Original Iron Dosage in Patients With Maintenance Hemodialysis"
protocolSection.statusModule.overallStatus
"UNKNOWN"
protocolSection.designModule.phases
["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • End-stage Renal Disease (protocolSection.conditionsModule.conditions)
  • Anemia (protocolSection.conditionsModule.conditions)
  • Cardiovascular Risk Factor (protocolSection.conditionsModule.conditions)
  • Inflammation (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.